F 0760
Ensure that residents are free from significant medication errors.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the failed to ensure that its residents are free of any significant medication
error for 1 (CR#1) of 5 residents reviewed for medication administration.CR#1 was ordered to receive 600
MG of Gabapentin in the evening for pain on 10/16/25 and 10/17/25 but was administered 300 MG both
evenings by MA B.MA B failed to follow physician orders or consult with a nurse for order clarification.These
failures could place residents at risks for increased pain, discomfort, and a diminished quality of
life.Findings include: Record review of CR#1's face-sheet reviewed 10/21/25, revealed a seventy-six year
old woman who was admitted to the facility on [DATE]. Her admitting diagnoses were a Type II Dens
fracture (a break in the odontoid process, the peg-like structure that connects the second vertebra (axis) to
the first vertebra (atlas) in the cervical spine), elevated white blood cell count, cervicalgia (pain in the neck
region), pain, and adult failure to thrive. Record review of CR#1's Pain Management Team Encounter notes
dated 10/16/25 stated that she was AAO x2-3. CR#1 had unspecified pain and treatment goals were
directly therapeutic and were incorporated to provide improvement and/or prevention of progression of the
condition, while providing a reasonable expectation of recovery. Record Review of CR#1's care plan
reviewed 10/21/25, displayed a focus on pain management initiated on 10/16/25. Interventions stated to
screen for pain on admission and daily. Assess to determine if experiencing pain. If pain was present,
conduct, and document pain assessment particularly location, nature, intensity, and duration of pain.
Record review of CR#1's orders dated 10/15/25 documented that CR#1 was to receive: 1. Gabapentin
Capsule 300 MG Give 1 capsule by mouth three times a day for nerve pain. 2. Gabapentin Capsule 300
MG Give 1 capsule by mouth two times a day for nerve pain equals 600mg for AM and PM doses. Record
review of CR#1's MAR dated October 2025 revealed the medications were administered as follows: 1300MG Gabapentin capsule by mouth two times a day (a.m. and p.m. doses that equaled 600 MG) for
nerve pain. * 10/16/25 at 9:00 a.m. dose was marked administered by MA A *10/16/25 at 9:00 p.m. dose
was marked administered by MA B. *10/17/25 at 9:00 a.m. dose was marked administered by MA A
*10/17/25 at 9:00 p.m. doses was marked administered by MA B. * 10/18/25 at 9:00 a.m., dose was marked
administered by the ADON. 1- 300 MG Gabapentin capsule to be given by mouth three times a day for
nerve pain. *10/16/25 at 9:00 a.m. dose was marked administered by MA A, *10/16/25 at 3:00 p.m. and the
9:00 p.m. doses were marked administered by MA B. *10/17/25 at 9:00 a.m. dose was marked administered
by MA A *10/17/25 at 3:00 p.m. and the 9:00 p.m. doses were marked administered by MA B *10/18/25 at
9:00 a.m., was marked administered by the ADON. In total, 5 Gabapentin 300 MG capsules should be
administered to CR#1 daily and a total of 12 capsules should have been administered from 10/16/25 to
10/18/25 at 9:00 a.m. Record review of CR#1's progress notes on 10/18/25 at 11:42 a.m. inputted by ADON
stated CR#1 had a change in condition where she was unresponsive. Nursing observation documented:
ADON was called to room due to change in condition. NP notified and orders given to send out via 911 to
hospital for further evaluation. Resident left with EMS at 11:54 a.m. via stretcher.
Residents Affected - Few
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
675495
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675495
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
11/26/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Laurel Court
3830 Mustang Road
Alvin, TX 77511
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
In an interview and observation on 10/21/25 at 12:14 p.m., MA A, stated she worked at the facility since
2020 and had stepped into the role as a medication aide in March 2025. She worked from 6 a.m. to 2 p.m.
and only remembered giving medications to CR#1 twice. She explained when she gave medication, she
would verify the orders by checking the resident's name with the picture, asking the resident to verify their
first and last name, and making sure the blister pack matched the orders. MA A took the Surveyor to the
medication cart and she reviewed CR #1's orders. She stated she saw there was one order to give 1 tab of
300 MG of Gabapentin 3xs a day and another to give 1 tab of 300 MG of Gabapentin 2xs a day. On her
shift of 6 a.m. to 2 p.m., she was ordered to give CR#1 2 capsules of Gabapentin. Reviewing the time
stamps in the MAR, she administered this medication on 10/16/25 at 10:34 a.m. and on 10/17/25 at 10:22
a.m. She stated although she saw two separate orders in the MAR, she did not feel like it was inputted by
accident, and she followed the orders as written. MA A stated she did not notice any adverse effects or any
changes in her behavior. She explained that if she suspected there was an overlap in medications or a
discrepancy, she would consult with one of the nurses. Inside the medication cart, there was one bottle of
Gabapentin 300 MG filled on 10/15/25 for 60 capsules for CR#1. A blister pack was also found for
Gabapentin 300 MG filled on 10/16/25 for 70 capsules. MA A recalled that she administered medication
from the Gabapentin bottle initially, but she switched over to the blister pack once it was delivered on
10/17/25. MA A counted the amount of medication remaining from both the pack and the bottle that
equaled a total of 130 capsules, 8 capsules 300 MG Gabapentin were missing from the count. In an
interview with MA B on 10/21/25 at 12:55 p.m., she stated that she had worked at the facility for 1 year and
she worked either the 6-2 a.m. shift or the 2-10 p.m. shift. On 10/16/25 and 10/17/25, she worked the 2-10
p.m. shift. She was familiar with CR#1 and after reviewing the MAR, she confirmed that she administered
300 MG of Gabapentin on 10/16/25 at 3:18 p.m. and 9:54 p.m. as well as on 10/17/25 at 3:40 p.m. and 9:02
p.m. She explained that she noticed that there were two orders of 300 MG of Gabapentin, but she figured it
was an entry error because she was admitted with the bottle and the blister pack was delivered the next
day. She stated that the combined orders of Gabapentin instructed to give CR#1 600 MG in the morning
and 600 MG in the evening. She explained that she thought that this was too much and a medication error,
so she decided to follow the order that stated to give CR#1 300 MG of Gabapentin 3xs a day and disregard
the additional order that instructed this medication also be administered 2xs a day. MA B explained that for
CR#1's evening medication passes, she only administered 1 300 MG capsule of Gabapentin and marked
that it was given on the other order although she only passed 1 capsule. She stated she did not ask any of
the nurses about CR#1's order but she stated that she was supposed to report it to the nurse if there were
any kind of suspected medication errors. She stated that the reason she did not report it to a nurse was
because she was working both halls and she forgot. In an interview on 10/22/25 at 9:43 a.m. with CR#1 in
the hospital, she was in bed wearing her neck brace while she grimaced and moaned in a lot of pain. She
stated that while she was in the nursing facility she was given a lot of medication, but she did not remember
what it was. She stated she did not feel any pain while she was there, and the nurses were nice to her but
was not feeling well enough to answer additional questions. In an interview on 10/22/25 at 4:43 p.m. with
the NP, she stated the last time she saw CR#1 was on 10/17/25 and she was demented but alert and
oriented x2. She explained she consulted with the facility's pain management team regarding her pain
medications. She stated she saw there were two orders of 300 MG of Gabapentin orders in the system
where one was to be given 3xs a day and the others was to be given 2xs a day. She stated for both
morning and evening administration, CR#1 was to receive 600 MG of Gabapentin. Two orders were
documented into the system for the medication
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
675495
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
675495
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
11/26/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Laurel Court
3830 Mustang Road
Alvin, TX 77511
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
because sometimes the system made them input each order in separately for it to populate when to
administer it in the MAR. She stated these doses of Gabapentin were normal doses and could still be
increased if needed. NP stated that she was unaware that CR#1 had not gotten her doses as she had
ordered and she did not receive any questions from facility nurses or staff regarding confusion with the two
300 MG Gabapentin orders. She stated that nurses always contacted her if they were confused and no one
should ever administer medication unless they have full understanding of the orders. In an interview with
the DON on 10/23/25 at 10:55 a.m. she was informed that MA B had not given CR#1 her 300 MG of
Gabapentin medication as ordered. She explained if an aide had confusion with the orders, they should
have reached out to a nurse for clarification. If the nurse had a question, they should reach out to the
physician. All orders were to be followed as documented in the computer. She explained the harm in CR#1
not receiving her medication as ordered would be increased pain for CR#1. Record review of MA B's
employee file documented that she was hired at the facility on 08/19/24 as a certified medication aide. Her
essential functions in this role were to administer medications as ordered by a physician under the
supervision of a licensed nurse in accordance with any state and federal regulations and consistent with
facility policy, record the administration of medications appropriately, and demonstrate knowledge of the five
rights (right patient, right drug, right dose, right route, and right time). Record review of the facility's policy
titled Adverse Consequences and Medication Errors revised April 2014 stated: A medication error is
defined as the preparation or administration of drugs or biological which is not in accordance with
physician's orders, manufacturer specifications, or accepted professional standards and principles of the
professional(s) providing services. Examples of medications errors include: a. Omission - a drug is ordered
but not administered; b. Unauthorized drug - a drug is administered without a physician's order; c. Wrong
dose (e.g., Dilantin 12 mL ordered, Dilantin 2 mL given); d. Wrong route of administration (e.g., ear drops
given in eye); e. Wrong dosage form (e.g., liquid ordered, capsule given); f. Wrong drug (e.g., vibramycin
ordered, vancomycin given); g. Wrong time; and/or h. Failure to follow manufacturer instructions and/or
accepted professional standards (e.g., failure to shake medication that is labeled shake well, crushing a
medication on the d
Event ID:
Facility ID:
675495
If continuation sheet
Page 3 of 3